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ABSTRACT  Bronchial asthma is characterized by the bronchial hyperresponsiveness 
and airway obstruction related to airway smooth muscle contraction. Eosinophilic airway 
inflammation is involved in its pathogenesis. To reproduce the condition, various animal models 
have been prepared. However, there are many models that do not reflect the spontaneous 
history of bronchial asthma onset in humans due to the mouse strain, sensitizing antigen, or 
administration method. In this study, we prepared a mouse model of which the mechanism is 
similar to that of human bronchial asthma.
　　Mite Extract-Dermatophagoides farinae  (Derf) antigen was transnasally administered to 
wild-type C57BL/6J mice (WT) 13 times. Subsequently, an airway hypersensitivity test (Mch 
PC200), specific antigen exposure test (ΔSRaw), bronchoalveolar lavage (BAL), and blood 
collection were performed to examine the presence or absence of asthma acquisition and 
differences in the local pulmonary levels of cytokines/chemokines in comparison with the 
physiological saline-treated group.
　　In the mite antigen-treated mice (WT/-Derf), bronchial hyperresponsiveness was enhanced, 
antigen-specific was increased airway resistance in comparison with physiological saline-
treated mice (WT/-Saline). In addition, the number of eosinophils in BAL fluid (BALF) was 
greater. Furthermore, there was a correlation among leukotrienes, eotaxin, and tissue inhibitors 
of metalloproteinase 1 in BALF, suggesting that the mechanism concerning eosinophilic airway 
inflammation involving in human bronchial asthma was reproduced.
　　In this study, we successfully established a mouse bronchial asthma model in which the 
pathogenesis resembles that in humans in comparison with conventional models, using Derf 
antigen alone and C57BL/6J mice.
 (Accepted on October 12, 2012)
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INTRODUCTION
　Bronchial asthma is characterized by the 
enhancement of airway hypersensitivity and airway 
obstruction related to airway smooth muscle 
contraction. Eosinophilic airway inflammation 
is involved in its pathogenesis1). Various animal 
models  have  been  prepared  to  c lar i fy  the 
pathogenesis of bronchial asthma and develop 
drugs2). In particular, an ovalbumin (OVA)-sensitized 
model, which was prepared using BALB/c mice, 
is known. However, Walsh et al. reported that, 
among similar OVA-sensitized models, airway 
hypersensitivity was acquired even in an eosinophil 
defect model consisting of Th2 lymphocyte-
predominant BALB/c mice, but not in another 
eosinophil defect model consisting of C57BL/6J 
mice, in which Th1 lymphocytes were predominant, 
as demonstrated in humans3). In the pathogenesis of 
bronchial asthma in humans, tissue disorder related 
to granular protein released by activated eosinophils 
may induce airway hypersensitivity4). However, 
Fattouh et al. indicated that airway hypersensitivity 
was enhanced in mite antigen-sensitized BALB/c 
mice with an eosinophil defect, as observed in 
wild-type mice5). Thus, Th2-predominant BALB/c 
mice  may  be  usefu l  fo r  acqui r ing  a i rway 
hypersensitivity, but the use of OVA, which is not 
a primary antigen for human bronchial asthma, and 
an intraperitoneal route for sensitization, which is 
not probable in the spontaneous course of human 
bronchial asthma onset, in many models raises 
issues. If the inhalation of a foreign antigen induces 
airway inflammation with eosinophil infiltration 
and airway hypersensitivity to acetylcholine/
methacholine, many characteristics of the condition 
may be common with those of human bronchial 
asthma. In C57BL/6 mice, transgenic and knock-
out mice involving many protein genes have been 
established. The preparation of a basic model with 
C57BL/6 background may be useful for clarifying 
the pathogenesis of allergic asthma and drug 
responsiveness. The grade of inflammation depends 
on the method of airway sensitization, the frequency 
of antigen administration, dose, period, and interval 
from the final dosing until analysis; the results must 
be carefully interpreted6).
　In this study, we prepared a mouse model 
resembling human bronchial asthma by conducting 
trans-airway sensitization with a primary antigen 
for human bronchial asthma, Mite Extract-
Dermatophagoides farinae (Derf) antigen, in 
C57BL/6J mice.
 
MATERIALS  AND  METHODS
Animal Model
　Mite antigen was transnasally administered to 
8-week-old, twenty-four female wild-type C57BL/6J 
mice (WT) as a mouse bronchial asthma model 
(sensitization group, WT/-Derf). Physiological 
saline was administered to control mice (control 
group, WT/-Saline). The results were compared 
between the two groups to confirm whether 
eosinophilic airway inflammation, the enhancement 
of airway hypersensitivity, and specific antigen 
exposure-induced airway obstruction, which are 
characteristics of bronchial asthma, are acquired. 
　Mite Extract-Dermatophagoides farinae (Derf) 
(LSL Co., Tokyo, Japan) was dissolved with 
distilled water and adjusted to 2 mg/ml with saline. 
Animals were anesthetized by the intraperitoneal 
administration of 50 mg/kg pentobarbital. After 
confirming sufficient anesthesia, 50μl of 2-mg/
ml Derf was administered into the nasal cavity. 
The antigen was administered 13 times at 4 times a 
week. Saline was similarly administered at the same 
volume and schedule. All experimental animals 
used in this study were under a protocol approved 
by the institutional animal care and use committee 
of Kawasaki Medical School (Differential Number 
10-026/ 12-012).
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Airway hypersensitivity test
　Using a nebulizer, mice were allowed to inhale 
methacholine at concentrations of 6.25, 12.5, 25, 
50, and 100 mg/ml. We compared concentrations 
(Mch PC 200) at which the airway resistance 
increased to 2-fold the value on the inhalation of 
physiological saline as a control value. Inhalation 
was performed for 3 minutes. After a 1-minute rest, 
the airway resistance was measured for 2 minutes 
(Pulmos, MIPS, Osaka, Japan). When Mch PC200 
was significantly lower than in the control group 
(physiological saline group), mice were regarded as 
positive.
Specific antigen exposure test
　The airway resistance was measured before and 
after transnasal Derf administration to evaluate the 
rate of increase (ΔsRaw) in comparison with the 
pretreatment airway resistance. When there was a 
significant increase in comparison with the control 
group, mice were regarded as positive.
Collection of blood/BAL fluid/lung tissue
　250 mg/kg pentobarbital was intraperitoneally 
adminis tered.  After  respiratory arrest  was 
confirmed, blood and BAL fluid (BALF) were 
collected. In some mice, BALF was not conducted, 
and May-Giemsa staining was performed in lung 
tissue specimens for pathological investigation.
ELISA
　IL-5, IL-13, IL-17, eotaxin, TNF-α, IFN-γ, 
matrix metalloproteinase 9 (MMP9), issue inhibitors 
of metalloproteinase 1 (TIMP1) (R&D Systems, 
Minneapolis, MN), and cysteinyl leukotrienes (C4, 
D4, E4) (Cyman Chemical Company, Ann Arbor, 
MI) in BALF were measured using ELISA. The 
detection limits were 15.6, 7.8, 10.9, 15.6, 10.9, 
9.4, 78.0, 37.5 and 7.8 pg/ml for IL-5, IL-13, IL-
17, eotaxin, TNF-α, IFN-γ, MMP9, TIMP1 1 
and cysteinyl leukotrienes, respectively. The Derf-
specific serum IgE and IgG1 were measured by 
ELISA as previously described7).
Statistical analysis
　For statistical analysis, Stat View 5.0® software 
(SAS Institute, Inc., Cary, NC, U.S.A.) was used.
The results were compared between the two groups 
using the Mann-Whitney U test. To examine 
the correlation among factors, Spearman’s rank 
correlation coefficient (non-parametric method) 
was used. Independent factors were identified using 
variable selection-multiple regression analysis. 
P<0.05 was regarded as significant.
 
RESULTS
　The serum levels of Derf-specific IgG1 and IgE 
significantly increased after Derf administration 
(Derf-specific IgG1: 1.44±0.43 vs. 0.001±0.003 
O.D., respectively, p<0.01; Derf-specific IgE: 0.24
±0.02 vs. 0.21±0.01 O.D., respectively, p<0.01; 
Table 1).
　Conce rn ing  a i rway  hype r sens i t i v i t y,  a 
methacholine inhalation test showed that the Mch 
PC200 value in the WT/-Derf was significantly lower 
than in the WT/-Saline (14.9±10.6 vs. 24.7±12.6 
mg/mL, respectively, p<0.05;Table 1).
　We investigated the airway resistance after 
exposure to a specific antigen. In the WT/-Derf, 
the airway resistance (ΔsRaw) 20 minutes after 
exposure was significantly higher than in the WT/-
Saline (25.8±24.9 vs. 3.99±1.79, respectively, 
p<0.01; Table 1).
　The total number of leukocytes in the BALF in 
the WT/-Derf was significantly higher than that 
in the WT/-Saline (91.7±43.2 vs. 15.8±10.2 
x 104/μL, respectively, p<0.05; Table 1). With 
respect to leukocyte fractions, the concentrations 
of eosinophils (35.3±31.7 vs. 0±0 x 104/μL, 
respectively, p<0.01), neutrophils (28.1±19.8 vs. 
0.05±0.09 x 104/μL, respectively, p<0.01), and 
lymphocytes (14.2±12.7 vs. 1.24±3.72 x 104/
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μL, respectively, p<0.01) in the WT/-Derf were 
significantly higher than in the WT/-Saline, as 
demonstrated for the cell concentration.
　The comparison of the BALF levels of cytokines 
and chemokines is shown in Table 1. The IL-13, 
IL-17, eotaxin and cysteinyl leukotriene levels in 
the WT/-Derf were significantly higher than in the 
WT/-Saline (p<0.05). Furthermore, the TIMP1 level 
in the WT/-Derf was also significantly higher than 
in the WT/-Saline (p<0.01). However, there were 
no significant differences in the MMP9 level or 
MMP9/TIMP1 ratio. On single correlation analysis 
involving Derf mice, there were strong correlations 
between eotaxin and leukotriene (r=0.87, p=0.02), 
between leukotriene and TIMP1 (r=0.76, p=0.04), 
and between eotaxin and TIMP1 (r=0.81, p=0.03; 
Table 2). Furthermore, there was a tendency of 
correlation between IL-13 and TIMP1 (r=0.68, 
p=0.07). Concerning factors correlated with 
airway hypersensitivity, there were no significant 
independent variables on multiple regression 
analysis. 
　We compared lung tissue specimens after May-
Giemsa staining (Fig.1). In the WT/-Derf, the 
infiltration of eosinophils was observed around the 
bronchus and blood vessels. However, there was 
no infiltration in the WT/-Saline. Neither the WT/-
Derf nor WT/-Saline showed fibrin deposition to the 
airway wall. Pathological remodeling could not be 
confirmed.
Table 1. Characteristics of Derf induced mouse asthma model.
WT/-Derf (n=9) WT/-Saline (n=10)  p
PC200, mg/ml 14.9 [8.1, 21.6] 24.7 [16.7, 32.7] 0.02
Delta SRaw 25.8 [0.90, 50.8] 3.99 [2.20, 5.77] < 0.01
Serum Df IgG1, o.d. 1.44 [1.1, 1.8] 0.001 [-0.001, 0.004] < 0.01
Serum Df IgE, o.d. 0.24 [0.23, 0.26] 0.21 [0.19, 0.22] < 0.01
BALF total number of
leukocytes, x 104/μL
91.7 [37.6, 145.1] 15.8 [5.6, 32.8] < 0.01
BALF Neutro, % 32.0 [10.9, 66.8] 0.55 [0.0, 2.32] < 0.01
BALF Eosino, % 37.4 [19.5, 55.4] N.D. < 0.01
BALF Eotaxin, pg/ml 8.6 [-0.92, 18.1] N.D. 0.02
BALF IL-5, pg/ml N.D. N.D.
BALF IFN-γ, pg/ml N.D. N.D.
BALF IL-13, pg/ml 17.1 [6.6, 27.7] N.D. < 0.01
BALF IL-17, pg/ml 23.5 [2.1, 44.9] N.D. < 0.01
BALF Leukotriene
C4+D4+E4, pg/ml
6,105 [5,047, 7,163] 722 [128, 1,317] < 0.01
BALF MMP-9, pg/ml 778 [-21, 1576] 14 [5, 23] 0.83
BALF TIMP-1, pg/ml 488 [208, 769] 43 [37, 49] < 0.01
BALF MMP-9/TIMP-1 ratio 3.5 [0.35, 6.7] 0.33 [0.12, 0.53] 0.58
mean [95%CI], Mann-Whitney U test was used for comparing WT/-Derf and WT/-Saline mice.
Abbreviation is a in the text.
N.D.: not detected, under the detection limit
Table 2. The signiﬁcant relationships among factors in serum and bronchial lavage ﬂuid in Derf-sensitized C57BL mice
r p-values
Serum IgE vs. BALF MMP-9/TIMP1 ratio 0.82 0.04
BALF eotaxin vs. BALF TIMP-1 0.81 0.03
BALF eotaxin vs. BALF leukotriene 0.87 0.02
BALF leukotriene vs. BALF TIMP-1 0.76 0.04
BALF IL-13 vs. BALF TIMP-1 0.68 0.07
To examine the correlation among factors, Spearman’s rank correlation coefﬁcient (non-parametric method) was used.
Abbreviation is a in the text.
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Fig. 1.　The tissue-based microscopic ﬁndings of bronchi of WT/-Saline (left) and WT/-Derf (right)
Eosinophils (allow head) is inﬁltrated in airway epithelium.
DISCUSSION
　In previous studies involving the preparation of 
a mouse model of bronchial asthma, sensitization/
intra-airway antigen administration methods varied, 
and the grade of inflammation depended on the 
frequency of antigen administration, dose, interval, 
and interval from the final dosing until analysis; the 
results must be carefully interpreted. As described 
by Walsh et al. and Fattouh et al., requirements to 
acquire airway hypersensitivity depend on the mouse 
strain3,5). Therefore, a mouse model reflecting the 
mode of the development of asthma in humans was 
necessary to clarify the pathogenesis of bronchial 
asthma and establish remedies. We prepared asthma 
model in C57BL/6 mouse, assuming that these may 
be overcome by increasing the period/frequency 
of sensitization at a 2-fold volume of mites, as 
considered the previous studies2). This is the first 
report on stable eosinophilic airway inflammation 
achieved by 13 sessions of airway sensitization at 50 
μl of 2-mg/ml Derf in C57BL/6J background mice. 
In this model, after transnasal Derf administration, 
the WT/-Derf met the following conditions: 
positive reactions on a specific antigen exposure 
test (ΔsRaw), positive reactions on a methacholine 
inhalation test (Mch PC200), increases in the serum 
levels of Derf-specific IgE and IgG1, and an 
increase in the number of eosinophils in the BALF, 
confirming that the characteristics of bronchial 
asthma could be reproduced. This mouse model may 
reflect the pathogenesis of human bronchial asthma, 
because the type of antigen, mouse strain, and route 
of sensitization differ from those in conventional 
models such as an OVA-sensitized model and that 
using BALB/c mice.
　The correlations between various chemokines 
and cytokines in BALF were evaluated. Eotaxin is a 
cytokine that induces the chemotaxis of eosinophils 
to local areas8). Eosinophils are one of the main 
producer of leukotrienes. In addition, eosinophils 
are stimulated by the leukotrienes that they produce, 
inducing airway contraction, mucous secretion, 
and the enhancement of vascular permeability9). 
The correlation between leukotrienes and eotaxin 
in BALF may reflect such a mechanism. Mast cells 
were not found in sites of lung inflammation and in 
the BALF of WT/Derf, although they were also one 
of the main leukotrienes producing cells. Mast cells 
may not play an important role in the development 
of airway hypersensitivity and airway inflammation 
in this model. Further examination is required to 
clarify the main leukotriens producing cells. 
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　Bronchial asthma is a chronic inflammatory 
disease of the airway, as described above. Under 
such an environment, an imbalance between 
extracellular matrix-decomposing enzymes, MMPs, 
and TIMPs may induce remodeling10,11).  The 
correlations between BALF leukotriene/Eotaxin/
IL-13, which are involved in local eosinophilic 
inflammation, and TIMP1, which is involved 
in the inhibition of remodeling, may reflect the 
development and reduction of eosinophilic airway 
inflammation12). However, MMP9 or MMP9/TIMP-
1, which are index of the airway remodeling were 
not increased in WT/-Derf. Pathological examination 
did not confirm remodeling of the WT/-Derf mice 
airway. To reproduce these characteristics, repeated 
antigen exposure stimulation may be needed. IFN-
γand IL-5, which could not be measured in this 
study (below the detection limit), may be detected 
by increasing exposure stimulation and/or by 
improvement of the measurement sensitivity such 
as concentration techniques. In the future, further 
examination is require.
　As the conclusions, this model may reproduce not 
only the characteristics of human bronchial asthma, 
such as eosinophilic inflammation of the airway, 
the enhancement of airway hypersensitivity, and 
specific antigen exposure-related obstruction of the 
airway, but also the chemotaxis of eosinophils to 
local areas and leukotriene-related inflammation, 
which are considered to be etiological factors 
for these characteristics, as well as a TIMP1-
mediated inhibitory mechanism. In this study, we 
successfully established a mouse bronchial asthma 
model reflecting the mode of onset in humans in 
comparison with conventional models, using Derf 
antigen and C57BL/6J mice. The results of analysis 
with this model may be useful for clarifying the 
pathogenesis of bronchial asthma and developing 
drugs in the future.
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